11 results
S-1
EX-3.2
AGIO
Agios Pharmaceuticals Inc
10 Jun 13
IPO registration
12:00am
II
DIRECTORS
General Powers
Number, Election and Qualification
Chairman of the Board; Vice Chairman of the Board
Tenure
Quorum
Action at Meeting … by Consent
Committees
Compensation of Directors
ARTICLE III
OFFICERS
Titles
Election
Qualification
Tenure
Resignation and Removal
- i -
Vacancies
President
8-K
EX-3.1
AGIO
Agios Pharmaceuticals Inc
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
Compensation of Directors
ARTICLE III OFFICERS
Titles
Election
Qualification
Tenure
Resignation and Removal
Vacancies
Chief Executive Officer
Vice … by the same person.
3.4 Tenure. Except as otherwise provided by law, by the Certificate of Incorporation or by theseBy-laws, each officer shall hold office
8-K
EX-3.2
AGIO
Agios Pharmaceuticals Inc
30 Jul 13
Unregistered Sales of Equity Securities
12:00am
of Directors
ARTICLE III
OFFICERS
Titles
Election
Qualification
Tenure
Resignation and Removal
Vacancies
President; Chief Executive Officer
Vice
DEF 14A
AGIO
Agios Pharmaceuticals Inc
7 Apr 14
Definitive proxy
12:00am
was chief executive officer of Pearl Therapeutics, a privately held biotechnology company. Prior to his tenure with Celgene, Mr. Karsen held executive … people in disease research and drug discovery in cancer, immune disorders, infectious diseases and neurodegenerative diseases. Prior to his tenure
424B4
x03yu
24 Jul 13
Prospectus supplement with pricing info
12:00am
S-1
g2tazq35sbpasry
10 Jun 13
IPO registration
12:00am
- Prev
- 1
- Next